The kick-off meeting was attended by 28 experts from 10 European countries (Austria, Belgium, Finland, France, Germany, Ireland, Netherlands, Poland, Slovenia and Switzerland) and 8 European institutes and organizations. Experts included representatives from patient organizations,

industry and regulatory bodies, health care professionals and health researchers. The call for source documents and the survey for examples of health CB-839 clinical trial checks were additionally answered by representatives from 6 countries (Latvia, Norway, Romania, Slovakia, Spain and the United Kingdom). The selected source documents mention criteria for the evaluation of e.g., medical tests and technologies, genetic tests and population prevention programs. The source documents were used by the project team (the authors of this article) to develop a first working draft and to assure that the proposed criteria are in line with existing criteria for related health tests and technologies. The source documents are listed in Annex C of the workshop agreement (see reference below). The project team identified the main topics and selected relevant items from the source documents for each of them. Examples of health checks in the survey include a diabetes risk questionnaire offered via the internet in the Netherlands,

a Gesundheits-check offered by general practitioners in Germany and a health screening offered by employers in Finland. The first draft of the quality criteria was presented and discussed in the second plenary workshop meeting (first LGK-974 ic50 internal review), and the revised version was posted publicly to seek comments from a wider

group of experts (external review). Fifty-eight comments Sodium butyrate were submitted, which were mostly related to refining definitions of the concepts used in specific criteria. These comments were discussed and approved during the third plenary workshop meeting (second internal review). The final version was published by CEN (CWA 16642 Health care services—Quality criteria for health checks) and is available from all national standardization institutes and via the EPAAC website (www.epaac.eu). A total of 43 experts contributed to one or more steps in the development of the criteria. These experts represented health policy agencies (n = 14), health research (n = 10), public health professionals (n = 8), industry (n = 4), patient advocacy organizations (n = 4) and medical professionals (n = 3). The competencies of the experts were diverse and included medicine, public health, health policy, law, health technology assessment, epidemiology, insurance, public health ethics, quality of care, education, patient advocacy and commerce. During the kick-off meeting, participants agreed that all relevant competencies were available, but that the insurer and payer perspective was underrepresented.